Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?

被引:182
作者
Lesclous, Philippe [1 ,2 ]
Najm, Semaan Abi [2 ]
Carrel, Jean-Pierre [2 ]
Baroukh, Brigitte [1 ]
Lombardi, Tommaso [2 ]
Willi, Jean-Pierre [3 ]
Rizzoli, Rene [4 ]
Saffar, Jean-Louis [1 ]
Samson, Jacky [2 ]
机构
[1] Univ Paris 05, Fac Chirurg Dent, Lab Reparat & Remodelages Orofaciaux, EA2496, Paris, France
[2] Univ Geneva, Fac Med, Div Stomatol & Oral Surg, Geneva, Switzerland
[3] Univ Hosp Geneva, Div Nucl Med, Geneva, Switzerland
[4] Univ Hosp Geneva, Dept Rehabil & Geriatr, Div Bone Dis, World Hlth Org Collaborating Ctr Osteoporosis Pre, Geneva, Switzerland
关键词
Aminobisphosphonates; Osteonecrosis; Inflammation; Macrophage/polykarions; Bone scintigraphy; IN-VITRO; MICRODAMAGE ACCUMULATION; BIOMECHANICAL PROPERTIES; MULTIPLE-MYELOMA; ZOLEDRONIC ACID; BONE TURNOVER; ALVEOLAR BONE; RISK-FACTORS; ALENDRONATE; OSTEOCLASTS;
D O I
10.1016/j.bone.2009.07.011
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Osteonecrosis of the jaw (ONJ) can be associated with nitrogen-containing bisphosphonates (NBPs) therapy. Various mechanisms of NBP-associated ONJ have been proposed and there is currently no consensus of the underlying pathogenesis. The detailed medical and dental histories of 30 ONJ patients treated with NBPs for malignant diseases (24) or osteoporosis (6) were analyzed. The necrotic bone was resected and analyzed histologically after demineralization. In 10 patients the perinecrotic bone was also resected and processed without demineralization. Alveolar bone samples from 5 healthy patients were used as controls. In 14 ONJ patients, serial technetium-99m-methylene diphosphonate scintigraphic scans were also available and confronted to the other data. Strong radionuclide uptake was detected in some patients several months before clinical diagnosis of ONJ. The medullary spaces of the necrotic bone were filled with bacterial aggregates. In the perinecrotic bone, the bacteria-free bone Marrow characteristically showed an inflammatory reaction. The number of medullary inflammatory cells taken as an index of inflammation allowed us to discriminate two inflammation grades in the ONJ samples. Low-grade inflammation, characterized by marrow fibrosis and low inflammatory cells infiltration, increased numbers of TRAP(+) mono- and multineacleated cells was seen in patients with bone exposure <2 cm(2). High-grade inflammation, associated with larger lesions, showed amounts of tartrate-resistant acid phosphatase(+)/calcitonin receptor(-) mono- and multinucleated cells, osteocyte apoptosis, hypervascularization and high inflammatory cell infiltration. The clinical extent of ONJ was statistically linked to the numbers of inflammatory cell. Taken together these data suggest that bone necrosis precedes clinical onset and is an inflammation-associated process. We hypothesize that from an initial focus, bone damage spreads centrifugally, both deeper into the jaw and towards the mucosa before the oral bone exposure and the clinical diagnosis of ONJ. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:843 / 852
页数:10
相关论文
共 52 条
[2]
THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION [J].
ADAMI, S ;
BHALLA, AK ;
DORIZZI, R ;
MONTESANTI, F ;
ROSINI, S ;
SALVAGNO, G ;
LOCASCIO, V .
CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) :326-331
[3]
Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment [J].
Allen, Matthew R. ;
Burr, David B. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2008, 66 (05) :987-994
[4]
Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment [J].
Allen, Matthew R. ;
Burr, David B. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (11) :1759-1765
[5]
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate [J].
Allen, Matthew R. ;
Iwata, Ken ;
Phipps, Roger ;
Burr, David B. .
BONE, 2006, 39 (04) :872-879
[6]
Allen MR., 2007, IBMS BoneKEy, V4, P49, DOI [DOI 10.1138/20060248, 10.1138/20060248]
[7]
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].
Bamias, A ;
Kastritis, E ;
Bamia, C ;
Moulopoulos, LA ;
Melakopoulos, L ;
Bozas, G ;
Koutsoukou, V ;
Gika, D ;
Anagnostopoulos, A ;
Papadimitriou, C ;
Terpos, E ;
Dimopoulos, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587
[8]
BARON R, 1977, CALC TISS RES, V22, P502
[9]
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells [J].
Coxon, Fraser P. ;
Thompson, Keith ;
Roelofs, Anke J. ;
Ebetino, F. Hal ;
Rogers, Michael J. .
BONE, 2008, 42 (05) :848-860
[10]
Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice:: Involvement of mevalonate pathway, TNFα, macrophages, and T-cells [J].
Deng, Xue ;
Yu, Zhiqian ;
Funayama, Hiromi ;
Yamaguchi, Kouji ;
Sasano, Takashi ;
Sugawara, Shunji ;
Endo, Yasuo .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (02) :152-161